Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

What Happened: After conducting a thorough analysis, LUDWIG sold 12,000 shares of Boston Scientific. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Patients can now receive interventional techniques that are no longer palliative in nature,” stated Samir Khan, DO, provider ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Introduction Neuropathic pain is a persistent pain condition caused by nerve damage or dysfunction in the nervous system. It is distinct from n ...

Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...

A University of Newcastle research team has secured a $940,000 National Health and Medical Research Council (NHMRC) Ideas Grant to examine the role of ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, focusing on innovative treatments. MISSION VIEJO, CALIFORNIA / ACCESS Newswire / ...